What else Glaxo said

Remember these two statements?

“Demonstrates remarkable efficacy and safety in the treatment of adolescent depression.”

“The results of the studies were disappointing. The possibility of obtaining a safety statement from this data was considered but rejected.”

The first is what Glaxo (GSK) told its sales reps after it tested Seroxat, an adult antidepressant on teenagers. The second is what company insiders had admitted internally.

But Glaxo went ahead and promoted Seroxat (Paxil) for children anyway.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: